beta
/Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers

Reviews

Join the dialogue

Submit a peer review to improve the scientific record

Summary